1. D. Wied Particlede (1966) ArticleTitleInhibitory effects of ACTH and related peptides on extinction of conditioned avoidance behavior in rats Proc. Soc. Exp. Biol. Med. 122 28–32 Occurrence Handle4287658

2. K. B. Kumar K. S. Karanth (1995) ArticleTitleEffects of ACTH and ACTH 4-10 on aversive memory retrieval in rats J. Neural Transm. Gen. Sect. 101 223–229 Occurrence Handle8695052 Occurrence Handle10.1007/BF01271559 Occurrence Handle1:CAS:528:DyaK2MXos1eit74%3D

3. D. Wied Particlede (1997) ArticleTitleNeuropeptides in learning and memory processes Behav. Brain Res. 83 83–90 Occurrence Handle9062665

4. K. M. Horvath P. Meerlo K. Felszeghy C. Nyakas P. G. Luiten (1999) ArticleTitleEarly postnatal treatment with ACTH4-9 analog ORG 2766 improves adult spatial learning but does not affect behavioural stress reactivity Behav. Brain Res. 106 181–188 Occurrence Handle10595434 Occurrence Handle1:CAS:528:DC%2BD3cXhs1Witw%3D%3D

5. A. Witter H. M. Greven D. Wied Particlede (1975) ArticleTitleCorrelation between structure, behavioral activity and rate of biotransformation of some ACTH4-9 analogs J. Pharmacol. Exp. Ther. 193 853–860 Occurrence Handle168348 Occurrence Handle1:CAS:528:DyaE2MXltVyks7Y%3D

6. F. L. Strand (2000) ArticleTitleDavid and Goliath – the slingshot that started the neuropeptide revolution Eur. J. Pharmacol. 405 3–12 Occurrence Handle11033309 Occurrence Handle10.1016/S0014-2999(00)00536-7 Occurrence Handle1:CAS:528:DC%2BD3cXnt1Sitrs%3D

7. F. L. Strand (2003) ArticleTitleNeuropeptides: General characteristics and neuropharmaceutical potential in treating CNS disorders Prog. Drug Res. 61 1–37 Occurrence Handle14674607 Occurrence Handle1:CAS:528:DC%2BD3sXpvFert7k%3D

8. I. P. Asmarin V. N. Nezavibat’ko N. F. Miasoedov A. A. Kamenskii I.A. Grivennikov M. A. Ponomareva-Stepnaia L. A. Andreeva Kaplan A. Ia V. B. Koshelev T. V. Riasina (1997) ArticleTitleA nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study) Zh. Vyssh. Nerv. Deiat. Im. I. P. Pavlova 47 420–430 Occurrence Handle9173745 Occurrence Handle1:STN:280:ByiB2s%2FnslM%3D

9. V. N. Potaman L. V. Antonova V. A. Dubynin D. A. Zaitzev A. A. Kamensky N. F. Myasoedov V. N. Nezavibatko (1991) ArticleTitleEntry of the synthetic ACTH(4-10) analogue into the rat brain following intravenous injection Neurosci. Lett. 127 133–136 Occurrence Handle1652713 Occurrence Handle10.1016/0304-3940(91)90912-D Occurrence Handle1:CAS:528:DyaK3MXlvFyqtrg%3D

10. I. P. Ashmarin V. N. Nezavibatko N. G. Levitskaya V. B. Koshelev A. A. Kamensky (1995) ArticleTitleDesign and investigation of an ACTH(4-10) analogue lacking d-amino acids and hydrophobic radicals Neurosci. Res. Commun. 16 105–112 Occurrence Handle1:CAS:528:DyaK2MXlvVehsbo%3D

11. O. V. Dolotov T. S. Seredenina N. G. Levitskaya A. A. Kamensky L. A. Andreeva L. Y. Alfeeva I. Y. Nagaev Y. A. Zolotarev I. A. Grivennikov Y. Engele N. F. Myasoedov (2003) ArticleTitleThe heptapeptide SEMAX stimulates BDNF expression in different areas of the rat brain in vivo Dokl. Biol. Sci. 391 292–295 Occurrence Handle14556513 Occurrence Handle10.1023/A:1025177812262 Occurrence Handle1:CAS:528:DC%2BD3sXmt1OgtLo%3D

12. Kaplan A. Ya A. G. Kochetova V. N. Nezavibathko T. V. Rjasina I. P. Ashmarin (1996) ArticleTitleSynthetic ACTH analogue semax displays nootropic-like activity in humans Neurosci. Res. Commun. 19 115–123 Occurrence Handle10.1002/(SICI)1520-6769(199609)19:2<115::AID-NRC171>3.0.CO;2-B Occurrence Handle1:CAS:528:DyaK28XntVCqtLo%3D

13. R. A. H. Adan W. H. Gispen (1997) ArticleTitleBrain melanocortin receptors: From cloning to function Peptides 18 1279–1287 Occurrence Handle9396074 Occurrence Handle10.1016/S0196-9781(97)00078-8 Occurrence Handle1:CAS:528:DyaK2sXntleqsLs%3D

14. R. A. H. Adan W. H. Gispen (2000) ArticleTitleMelanocortins and the brain: From effects via receptors to drug targets Eur. J. Pharmacol. 405 13–24 Occurrence Handle11033310 Occurrence Handle10.1016/S0014-2999(00)00537-9 Occurrence Handle1:CAS:528:DC%2BD3cXnt1Sitrg%3D

15. T. Kishi C. J. Aschkenasi C. E. Lee K. G. Mountjoy C. B. Saper J. K. Elmquist (2003) ArticleTitleExpression of melanocortin 4 receptor mRNA in the central nervous system of the rat J. Comp. Neurol. 457 213–235 Occurrence Handle12541307 Occurrence Handle10.1002/cne.10454 Occurrence Handle1:CAS:528:DC%2BD3sXhs12jtro%3D

16. R. A. H. Adan J. Oosterom G. Ludvigsdottir J. H. Brakkee J. P. H. Burbach W. H. Gispen (1994) ArticleTitleIdentification of antagonists for MC3, MC4 and MC5 receptors Eur. J. Pharmacol. 269 331–337 Occurrence Handle7895772 Occurrence Handle1:CAS:528:DyaK2MXitlWqtr4%3D

17. D. H. Versteeg M. P. Crom ParticleDe A. H. Mulder (1986) ArticleTitleACTH-(1-24) and alpha-MSH antagonize dopamine receptor-mediated inhibition of striatal dopamine and acetylcholine release Life Sci. 38 835–840 Occurrence Handle3005796 Occurrence Handle10.1016/0024-3205(86)90600-4 Occurrence Handle1:CAS:528:DyaL28Xht1ent7c%3D

18. W. J. Florijn T. Boer ParticleDe J. A. Tonnaer D. H. Versteeg (1992) ArticleTitleCharacterization of the inhibitory effect of adrenocorticotropin/melanocyte-stimulating hormone-like peptides on the binding of dopamine receptor ligands to the dopamine D2 receptor in vitro J. Pharmacol. Exp. Ther. 263 787–792 Occurrence Handle1331413 Occurrence Handle1:CAS:528:DyaK3sXntl2jtA%3D%3D

19. W. J. Florijn A. J. Holtmaat H. Lang Particlede H. Spierenburg W. H. Gispen D. H. Versteeg (1993) ArticleTitlePeptide-induced grooming behavior and caudate nucleus dopamine release Brain Res. 625 169–172 Occurrence Handle8242396 Occurrence Handle10.1016/0006-8993(93)90151-C Occurrence Handle1:CAS:528:DyaK3sXms1ehs7s%3D

20. J. Lindblom B. Opmane F. Mutulis I. Mutule R. Petrovska V. Klusa L. Bergstrom J. E. S. Wikberg (2001) ArticleTitleThe MC4 receptor mediates α-MSH induced release of nucleus accumbens dopamine Neuroreport 12 2155–2158 Occurrence Handle11447325 Occurrence Handle1:CAS:528:DC%2BD3MXls1enu7c%3D

21. N. Kawashima S. Chaki S. Okuyama (2003) ArticleTitleElectrophysiological effects of melanocortin receptor ligands on neuronal activities of monoaminergic neurons in rats Neurosci. Lett. 353 119–122 Occurrence Handle14664915 Occurrence Handle10.1016/j.neulet.2003.09.024 Occurrence Handle1:CAS:528:DC%2BD3sXps1Oit7g%3D

22. D. M. Barros L. A. Izquierdo J. H. Medina I. Izquierdo (2003) ArticleTitlePharmacological findings contribute to the understanding of the main physiological mechanisms of memory retrieval Curr. Drug Target. CNS Neurol. Disord. 2 81–94 Occurrence Handle1:CAS:528:DC%2BD3sXislOntr0%3D

23. V. Hefco K. Yamada A. Hefco L. Hritcu A. Tiron T. Nabeshima (2003) ArticleTitleRole of the mesotelencephalic dopamine system in learning and memory processes in the rat Eur. J. Pharmacol. 475 55–60 Occurrence Handle12954359 Occurrence Handle10.1016/S0014-2999(03)02115-0 Occurrence Handle1:CAS:528:DC%2BD3sXmvFSjs7c%3D

24. T. M. Jay (2003) ArticleTitleDopamine: A potential substrate for synaptic plasticity and memory mechanisms Prog. Neurobiol. 69 375–390 Occurrence Handle12880632 Occurrence Handle10.1016/S0301-0082(03)00085-6 Occurrence Handle1:CAS:528:DC%2BD3sXls1ersL8%3D

25. I. I. Afanas’ev E. A. Anderzhanova V. S. Kudrin K. S. Rayevsky (2001) ArticleTitleEffects of amphetamine and sydnocarb on dopamine release and free radical generation in rat striatum Pharmacol. Biochem. Behav. 69 653–658 Occurrence Handle11509228 Occurrence Handle1:CAS:528:DC%2BD3MXlvFWrsLc%3D

26. G. Paxinos C. Watson (1986) The Rat Brain Stereotaxic Coordinates EditionNumber2 Academic Press Sydney

27. E. Anderzhanova K. S. Rayevsky P. Saransaari S. S. Oja (2003) ArticleTitleEffect of sulpiride on the amphetamine-induced changes in extracellular dopamine, DOPAC, and hydroxyl radical generation in the rat striatum Neurochem. Res. 28 1241–1248 Occurrence Handle12834265 Occurrence Handle10.1023/A:1024240814923 Occurrence Handle1:CAS:528:DC%2BD3sXks1OrtLc%3D

28. J. A. Boer ParticleDen I. M. Vliet Particlevan H. G. Westenberg (1995) ArticleTitleRecent developments in the psychopharmacology of social phobia Eur. Arch. Psychiat. Clin. Neurosci. 244 309–316 Occurrence Handle10.1007/BF02190409

29. S. Chaki S. Hirota T. Funakoshi Y. Suzuki S. Suetake T. Okubo T. Ishii A. Nakazato S. Okuyama (2003) ArticleTitleAnxiolytic-like and antidepressant-like activities of MCL0129 {1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine}, a novel and potent nonpeptide antagonist of the melanocortin-4 receptor J. Pharmacol. Exp. Ther. 304 818–826 Occurrence Handle12538838 Occurrence Handle10.1124/jpet.102.044826 Occurrence Handle1:CAS:528:DC%2BD3sXpvVCltg%3D%3D

30. M. I. Shadrina O. V. Dolotov I. A. Grivennikov P. A. Slominsky L. A. Andreeva L. S. Inozemtseva S. A. Limborska N. F. Myasoedov (2001) ArticleTitleRapid induction of neurotrophin mRNAs in rat glial cell cultures by Semax, an adrenocorticotropic hormone analog Neurosci. Lett. 308 115–118 Occurrence Handle11457573 Occurrence Handle10.1016/S0304-3940(01)01994-2 Occurrence Handle1:CAS:528:DC%2BD3MXltF2jsrY%3D

31. A. Blochl C. Sirrenberg (1996) ArticleTitleNeurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors J. Biol. Chem. 271 21100–21107 Occurrence Handle8702878 Occurrence Handle1:STN:280:BymA2Mrks1w%3D

32. J. Goggi I. A. Pullar S. L. Carney H. F. Bradford (2002) ArticleTitleModulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in␣vitro Brain Res. 941 34–42 Occurrence Handle12031545 Occurrence Handle10.1016/S0006-8993(02)02505-2 Occurrence Handle1:CAS:528:DC%2BD38XjvVSgs78%3D

33. J. Goggi I. A. Pullar S. L. Carney H. F. Bradford (2003) ArticleTitleSignalling pathways involved in the short-term potentiation of dopamine release by BDNF Brain Res. 968 156–161 Occurrence Handle12644273 Occurrence Handle10.1016/S0006-8993(03)02234-0 Occurrence Handle1:CAS:528:DC%2BD3sXitV2huro%3D

34. M. Narita K. Aoki M. Takagi Y. Yajima T. Suzuki (2003) ArticleTitleImplication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine Neuroscience 119 767–775 Occurrence Handle12809697 Occurrence Handle10.1016/S0306-4522(03)00099-X Occurrence Handle1:CAS:528:DC%2BD3sXksValtbo%3D

35. K. Hashimoto E. Shimizu M. Iyo (2004) ArticleTitleCritical role of brain-derived neurotrophic factor in mood disorders Brain Res. Brain Res. Rev. 45 104–114 Occurrence Handle15145621 Occurrence Handle10.1016/j.brainresrev.2004.02.003 Occurrence Handle1:CAS:528:DC%2BD2cXktVCltbc%3D

36. R. S. Duman (2004) ArticleTitleRole of neurotrophic factors in the etiology and treatment of mood disorders Neuromol. Med. 5 11–25 Occurrence Handle10.1385/NMM:5:1:011 Occurrence Handle1:CAS:528:DC%2BD2cXivVCiuro%3D

37. A. A. Garza T. G. Ha C. Garcia M. J. Chen A. A. Russo-Neustadt (2004) ArticleTitleExercise, antidepressant treatment, and BDNF mRNA expression in the aging brain Pharmacol. Biochem. Behav. 77 209–220 Occurrence Handle14751447 Occurrence Handle10.1016/j.pbb.2003.10.020 Occurrence Handle1:CAS:528:DC%2BD2cXnvVOjtw%3D%3D

38. F. Karege G. Perret G. Bondolfi M. Schwald G. Bertschy J. M. Aubry (2002) ArticleTitleDecreased serum brain-derived neurotrophic factor levels in major depressed patients Psychiat. Res. 109 143–148 Occurrence Handle10.1016/S0165-1781(02)00005-7 Occurrence Handle1:CAS:528:DC%2BD38Xitlaqt70%3D

39. S. J. Tsai (2004) ArticleTitleDown-regulation of the Trk-B signal pathway: The possible pathogenesis of major depression Med. Hypotheses 62 215–218 Occurrence Handle14962629 Occurrence Handle1:CAS:528:DC%2BD2cXhtVOltb0%3D